English

    Overview

  • Dr. Sandeep Satsangi is a highly skilled hepatologist and liver transplant physician in Old Airport Road, Bangalore. He is currently practising as a Lead Consultant - Hepatology at Manipal Hospital, Old Airport Road, Bangalore, bringing over a decade of specialised clinical experience in the diagnosis, management, and advanced treatment of complex liver diseases. Renowned for his precision, evidence-based approach, and patient-centric care, Dr. Satsangi has earned a reputation as one of the best hepatologists in Bangalore, offering world-class services in liver disease management, liver transplantation, and multiorgan care.

  • Dr. Satsangi’s medical journey began with an MBBS from MNR Medical College, Sangareddy where he secured distinctions in several subjects like pharmacology, microbiology, social & preventive medicine, and paediatrics. He subsequently did an M.D in Internal Medicine from Kasturba Medical College, Mangalore, under Manipal University. Dr Satsangi was also awarded as the university topper in his MD examination. Dr Satsangi then specialised in the field of liver diseases and liver transplantation by completing a prestigious D.M in Hepatology from the highly reputed PGIMER, Chandigarh. Dr. Satsangi consistently topped his class and the exit exam held by the institution. He also performed extensive research and published extensively in the field of hepatology and received several accolades for his academic excellence. His early exposure to complex liver pathologies during his senior residency at PGIMER equipped him with extensive hands-on experience in managing acute and chronic liver disorders, hepatitis, cirrhosis, portal hypertension, and liver failure.

  • Currently, at Manipal Hospitals, Bangalore, Dr. Satsangi leads a comprehensive liver care programme encompassing advanced hepatology consultations, liver transplantation, and management of multiorgan complications associated with liver disease. His expertise spans from managing fatty liver, alcohol related liver disease, liver cancer, acute-on-chronic liver failure (ACLF), viral hepatitis, autoimmune liver diseases, cirrhosis, and liver complications arising from systemic illnesses. He is also actively involved in pre- and post-liver transplant care, where he plays a pivotal role in optimizing patients prior to a liver transplant and ensures long term follow-up of recipients for optimal outcomes. Dr. Satsangi also plays a key role in evaluation of live liver donors & their perioperative management ensuring their smooth recovery and liver regeneration.

  • Dr. Satsangi has contributed significantly to medical research and education. He has presented multiple award-winning oral and poster papers at national and international conferences, including ISGCON, APASL, AASLD, and INASL. His publications cover a broad spectrum of hepatology topics, such as liver transplantation outcomes, management of hepatitis C with direct-acting antivirals, liver disease in systemic disorders, and innovative strategies for ACLF management including extracorporeal therapies for liver failure. These contributions have positioned him as a leader and academic mentor in the field of hepatology.

  • In addition to his clinical and academic accomplishments, Dr. Satsangi has actively worked to improve community awareness and physician training in liver care. He has collaborated on telemedicine initiatives, such as the ‘ECHO’ program in Punjab, training community-level physicians in early detection and management of liver diseases. He also served as Assistant Editor of the Journal of Clinical and Experimental Hepatology which is the official journal of INASL, gaining experience in peer-reviewed publication processes and scientific review.

  • Fluent in English, Hindi, Telugu, Punjabi, and Kannada, Dr. Satsangi is known for his approachable and empathetic communication with patients and families, guiding them through complex treatment decisions with clarity and compassion. Combining advanced clinical skills, international-standard protocols, and personalised patient care, he is recognised as the best hepatologist in Bangalore for patients seeking specialised liver disease management and transplant care. His practice seamlessly integrates cutting-edge medical science with an unwavering commitment to improving patient outcomes, making him a preferred choice for patients across Bangalore and surrounding regions.

  • Field of Expertise

  • Complex Hepatobiliary Conditions
  • Non-alcoholic fatty liver disease
  • Alcoholic liver diseases
  • Cirrhosis of the liver
  • Acute liver failure
  • Liver Cancer
  • Liver Transplantation
  • Liver Cancer
  • Liver Transplantation
  • Languages Spoken

  • English
  • Hindi
  • Telugu
  • Kannada
  • Awards & Achievements

  • MD: Best outgoing student 2011 batch, scored first rank in the Cardiology-Respiratory Medicine exam, and secured first prize in the M.D intercollegiate quiz competition (2013) held at Cochin, India.
  • DM: Topped the exam held at the distinguished institute of PGI, Chandigarh in 2016.
  • He also received the FIRST prize in the plenary session for the best paper award for an oral presentation on “Monocyte HLA-DR expression, neutrophil oxidative burst capacity and cytokine analysis in patients with decompensated cirrhosis with and without acute-on-chronic liver failure (ACLF)” in Delhi.
  • Served as the Assistant Editor of the prestigious Journal of Clinical and Experimental Hepatology from July 2016 to July 2017, which is an International peer-reviewed journal of Hepatology.
  • Actively assisted Prof. R.K Dhiman and his team in the process of devising the scientific program and abstract evaluation for INASL 2016 & ISHEN 2017.
  • Was actively involved in training the community level physicians in the state of Punjab, India in the field of Hepatology under the guidance of Prof. R.K Dhiman via. the program ‘ECHO’, which involves telemedicine services.
  • Talks & Publications

  • Hepatic Visceral Crisis in Breast Cancer: Targeting an Old Enemy With “Precision” Resulting in Excellent Outcomes. JCEH 2025.
  • Exploring the prevalence, clinical parameters and impact of culture proven ascitic fluid infections in Cirrhosis: A multi-center study. JCEH 2025.
  • The potential liver donor with tuberculosis: A fresh look at international recommendations based on a survey of practice in Indian liver transplant centres. National Med Journal 2022.
  • Fatal Herpes Simplex Hepatitis in a Live Liver Donor. JCEH 2025.
  • Kaur S, Satsangi S et al. Awareness regarding hepatitis B prevention and management of hepatitis B virus positive patients among nurses. J Postgrad Med Edu Res 2023.
  • Satsangi S, Taneja S. Abnormal LFTs in Rheumatic diseases. Rheumatology Clinics 2023.
  • Satsangi S, Taneja S. Anti Tubercular Therapy related hepatitis. Tuberculosis and GIT 2022.
  • Satsangi S et al. Current and new drugs for COVID 19 treatment and its effects on the liver. J Clin Transl Hepatol 2021.
  • Decentralized Care with Generic Direct-Acting Antivirals in the Management of Chronic Hepatitis C in a Public Health Care Setting. J Hepatol. July 2019.
  • Direct-acting antiviral Therapy Is Safe and Effective in Pediatric Chronic Hepatitis C: The Public Health Perspective. J Pediatr Gastroenterol Nutr. 2019.
  • Pre-Emptive Transjugular Intrahepatic Portosystemic Shunt for Acute Variceal Bleed: Choose Your Patient Well! Hepatology 2019.
  • Noradrenaline for Hepatorenal Syndrome in Patients with Acute-on Chronic Liver Failure: Hope Remains! Hepatology 2018
  • Satsangi S. Response to terlipressin in hepatorenal syndrome- Predict to prognosticate! Clin Gastroenterol Hepatol. 2018.
  • Satsangi S. Post-Paracentesis Hemoperitoneum - Time to Become More Careful! Liver Int. 2018.
  • Satsangi S. To use entecavir, tenofovir disoproxil fumarate or tenofovir alafenamide. It's all about choosing the right patient! Eur J Gastroenterol Hepatol. 2018.
  • Satsangi S. Immune-tolerant chronic hepatitis B infection- Is the liver really tolerating? J Clin Exp Hepatol. 2018.
  • Satsangi S. Khat consumption induced chronic liver disease: is it all autoimmune?. J Liver Res Disord Ther. 2018;4(2):64.
  • Satsangi S, Mehta M, Duseja A, Taneja S, Dhiman RK, Chawla Y. Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C. J Gastroenterol Hepatol. 2016.
  • Mehta M, Satsangi S, Duseja A, et al. Can Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Co-Exist? J Clin Exp Hepatol 2017.
  • Sakpal M, Satsangi S, Mehta M et al. Vitamin D supplementation in patients with Nonalcoholic Fatty Liver Disease - A Randomised Controlled Trial. J Gastroenterol Hepatol Open 2017.
  • Satsangi S, Acharya V, Kini H, Anupama K. An unusual cause of lung mass in a young female. Lung India. 2014;31(2):188-90.
  • Satsangi S, Chawla YK. Viral hepatitis: Indian scenario. Med J Armed Forces India. 2016;72(3):204-10.
  • Dhiman RK, Satsangi S, Grover GS, Puri P. Tackling the burden of hepatitis C in Punjab, India. J Clin Exp Hepatol. 2016 Sep;6(3):224-232.
  • Chronic hepatitis C: Suspect, Detect & Treat. Sandeep Satsangi, Yogesh. K Chawla. (Association of physicians of India 'Medicine update' 2015).
  • Recent advances in the medical management of portal hypertesion. Sandeep Satsangi, Yogesh. K Chawla. (Association of physicians of India 'Medicine update' 2016)
  • How will I manage CHC genotype-1 after the introduction of Direct-Acting Antivirals. Sandeep Satsangi, Yogesh. K Chawla. (Progress in Gastroenterology & Hepatology 2015)
  • Satsangi S, Gupta N. Rheumatologic Manifestations of Viral Hepatitis B and C. Hepatitis. 2015.
  • Satsangi S, Dhiman RK. Combating the wrath of viral hepatitis in India. Indian J Med Res. 2016 Jul; 144(1): 1–5.
  • Treatment of Hepatitis B in the Indian subcontinent. Sandeep Satsangi, Yogesh. K Chawla. Indian College of Physicians Monograph 2017.
  • Acute-on-chronic liver failure - The Newer Paradigm. Sandeep Satsangi, Yogesh. K Chawla. Indian College of Physicians Monograph 2017.
  • NASH: Do we really have an Effective Treatment? Sandeep Satsangi, Ajay Duseja. (Association of physicians of India 'Medicine update' 2017).
  • Dhiman RK, Satsangi S. Autoimmune diseases of the liver. Indian J Med Res. 2017 Jan; 145(1): 151–153.

    Languages Spoken

  • English
  • Hindi
  • Telugu
  • Kannada
  • Overview

  • Dr. Sandeep Satsangi is a highly skilled hepatologist and liver transplant physician in Old Airport Road, Bangalore. He is currently practising as a Lead Consultant - Hepatology at Manipal Hospital, Old Airport Road, Bangalore, bringing over a decade of specialised clinical experience in the diagnosis, management, and advanced treatment of complex liver diseases. Renowned for his precision, evidence-based approach, and patient-centric care, Dr. Satsangi has earned a reputation as one of the best hepatologists in Bangalore, offering world-class services in liver disease management, liver transplantation, and multiorgan care.

  • Dr. Satsangi’s medical journey began with an MBBS from MNR Medical College, Sangareddy where he secured distinctions in several subjects like pharmacology, microbiology, social & preventive medicine, and paediatrics. He subsequently did an M.D in Internal Medicine from Kasturba Medical College, Mangalore, under Manipal University. Dr Satsangi was also awarded as the university topper in his MD examination. Dr Satsangi then specialised in the field of liver diseases and liver transplantation by completing a prestigious D.M in Hepatology from the highly reputed PGIMER, Chandigarh. Dr. Satsangi consistently topped his class and the exit exam held by the institution. He also performed extensive research and published extensively in the field of hepatology and received several accolades for his academic excellence. His early exposure to complex liver pathologies during his senior residency at PGIMER equipped him with extensive hands-on experience in managing acute and chronic liver disorders, hepatitis, cirrhosis, portal hypertension, and liver failure.

  • Currently, at Manipal Hospitals, Bangalore, Dr. Satsangi leads a comprehensive liver care programme encompassing advanced hepatology consultations, liver transplantation, and management of multiorgan complications associated with liver disease. His expertise spans from managing fatty liver, alcohol related liver disease, liver cancer, acute-on-chronic liver failure (ACLF), viral hepatitis, autoimmune liver diseases, cirrhosis, and liver complications arising from systemic illnesses. He is also actively involved in pre- and post-liver transplant care, where he plays a pivotal role in optimizing patients prior to a liver transplant and ensures long term follow-up of recipients for optimal outcomes. Dr. Satsangi also plays a key role in evaluation of live liver donors & their perioperative management ensuring their smooth recovery and liver regeneration.

  • Dr. Satsangi has contributed significantly to medical research and education. He has presented multiple award-winning oral and poster papers at national and international conferences, including ISGCON, APASL, AASLD, and INASL. His publications cover a broad spectrum of hepatology topics, such as liver transplantation outcomes, management of hepatitis C with direct-acting antivirals, liver disease in systemic disorders, and innovative strategies for ACLF management including extracorporeal therapies for liver failure. These contributions have positioned him as a leader and academic mentor in the field of hepatology.

  • In addition to his clinical and academic accomplishments, Dr. Satsangi has actively worked to improve community awareness and physician training in liver care. He has collaborated on telemedicine initiatives, such as the ‘ECHO’ program in Punjab, training community-level physicians in early detection and management of liver diseases. He also served as Assistant Editor of the Journal of Clinical and Experimental Hepatology which is the official journal of INASL, gaining experience in peer-reviewed publication processes and scientific review.

  • Fluent in English, Hindi, Telugu, Punjabi, and Kannada, Dr. Satsangi is known for his approachable and empathetic communication with patients and families, guiding them through complex treatment decisions with clarity and compassion. Combining advanced clinical skills, international-standard protocols, and personalised patient care, he is recognised as the best hepatologist in Bangalore for patients seeking specialised liver disease management and transplant care. His practice seamlessly integrates cutting-edge medical science with an unwavering commitment to improving patient outcomes, making him a preferred choice for patients across Bangalore and surrounding regions.

  • Field of Expertise

  • Complex Hepatobiliary Conditions
  • Non-alcoholic fatty liver disease
  • Alcoholic liver diseases
  • Cirrhosis of the liver
  • Acute liver failure
  • Liver Cancer
  • Liver Transplantation
  • Liver Cancer
  • Liver Transplantation
  • Awards & Achievements

  • MD: Best outgoing student 2011 batch, scored first rank in the Cardiology-Respiratory Medicine exam, and secured first prize in the M.D intercollegiate quiz competition (2013) held at Cochin, India.
  • DM: Topped the exam held at the distinguished institute of PGI, Chandigarh in 2016.
  • He also received the FIRST prize in the plenary session for the best paper award for an oral presentation on “Monocyte HLA-DR expression, neutrophil oxidative burst capacity and cytokine analysis in patients with decompensated cirrhosis with and without acute-on-chronic liver failure (ACLF)” in Delhi.
  • Served as the Assistant Editor of the prestigious Journal of Clinical and Experimental Hepatology from July 2016 to July 2017, which is an International peer-reviewed journal of Hepatology.
  • Actively assisted Prof. R.K Dhiman and his team in the process of devising the scientific program and abstract evaluation for INASL 2016 & ISHEN 2017.
  • Was actively involved in training the community level physicians in the state of Punjab, India in the field of Hepatology under the guidance of Prof. R.K Dhiman via. the program ‘ECHO’, which involves telemedicine services.
  • Talks & Publications

  • Hepatic Visceral Crisis in Breast Cancer: Targeting an Old Enemy With “Precision” Resulting in Excellent Outcomes. JCEH 2025.
  • Exploring the prevalence, clinical parameters and impact of culture proven ascitic fluid infections in Cirrhosis: A multi-center study. JCEH 2025.
  • The potential liver donor with tuberculosis: A fresh look at international recommendations based on a survey of practice in Indian liver transplant centres. National Med Journal 2022.
  • Fatal Herpes Simplex Hepatitis in a Live Liver Donor. JCEH 2025.
  • Kaur S, Satsangi S et al. Awareness regarding hepatitis B prevention and management of hepatitis B virus positive patients among nurses. J Postgrad Med Edu Res 2023.
  • Satsangi S, Taneja S. Abnormal LFTs in Rheumatic diseases. Rheumatology Clinics 2023.
  • Satsangi S, Taneja S. Anti Tubercular Therapy related hepatitis. Tuberculosis and GIT 2022.
  • Satsangi S et al. Current and new drugs for COVID 19 treatment and its effects on the liver. J Clin Transl Hepatol 2021.
  • Decentralized Care with Generic Direct-Acting Antivirals in the Management of Chronic Hepatitis C in a Public Health Care Setting. J Hepatol. July 2019.
  • Direct-acting antiviral Therapy Is Safe and Effective in Pediatric Chronic Hepatitis C: The Public Health Perspective. J Pediatr Gastroenterol Nutr. 2019.
  • Pre-Emptive Transjugular Intrahepatic Portosystemic Shunt for Acute Variceal Bleed: Choose Your Patient Well! Hepatology 2019.
  • Noradrenaline for Hepatorenal Syndrome in Patients with Acute-on Chronic Liver Failure: Hope Remains! Hepatology 2018
  • Satsangi S. Response to terlipressin in hepatorenal syndrome- Predict to prognosticate! Clin Gastroenterol Hepatol. 2018.
  • Satsangi S. Post-Paracentesis Hemoperitoneum - Time to Become More Careful! Liver Int. 2018.
  • Satsangi S. To use entecavir, tenofovir disoproxil fumarate or tenofovir alafenamide. It's all about choosing the right patient! Eur J Gastroenterol Hepatol. 2018.
  • Satsangi S. Immune-tolerant chronic hepatitis B infection- Is the liver really tolerating? J Clin Exp Hepatol. 2018.
  • Satsangi S. Khat consumption induced chronic liver disease: is it all autoimmune?. J Liver Res Disord Ther. 2018;4(2):64.
  • Satsangi S, Mehta M, Duseja A, Taneja S, Dhiman RK, Chawla Y. Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C. J Gastroenterol Hepatol. 2016.
  • Mehta M, Satsangi S, Duseja A, et al. Can Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Co-Exist? J Clin Exp Hepatol 2017.
  • Sakpal M, Satsangi S, Mehta M et al. Vitamin D supplementation in patients with Nonalcoholic Fatty Liver Disease - A Randomised Controlled Trial. J Gastroenterol Hepatol Open 2017.
  • Satsangi S, Acharya V, Kini H, Anupama K. An unusual cause of lung mass in a young female. Lung India. 2014;31(2):188-90.
  • Satsangi S, Chawla YK. Viral hepatitis: Indian scenario. Med J Armed Forces India. 2016;72(3):204-10.
  • Dhiman RK, Satsangi S, Grover GS, Puri P. Tackling the burden of hepatitis C in Punjab, India. J Clin Exp Hepatol. 2016 Sep;6(3):224-232.
  • Chronic hepatitis C: Suspect, Detect & Treat. Sandeep Satsangi, Yogesh. K Chawla. (Association of physicians of India 'Medicine update' 2015).
  • Recent advances in the medical management of portal hypertesion. Sandeep Satsangi, Yogesh. K Chawla. (Association of physicians of India 'Medicine update' 2016)
  • How will I manage CHC genotype-1 after the introduction of Direct-Acting Antivirals. Sandeep Satsangi, Yogesh. K Chawla. (Progress in Gastroenterology & Hepatology 2015)
  • Satsangi S, Gupta N. Rheumatologic Manifestations of Viral Hepatitis B and C. Hepatitis. 2015.
  • Satsangi S, Dhiman RK. Combating the wrath of viral hepatitis in India. Indian J Med Res. 2016 Jul; 144(1): 1–5.
  • Treatment of Hepatitis B in the Indian subcontinent. Sandeep Satsangi, Yogesh. K Chawla. Indian College of Physicians Monograph 2017.
  • Acute-on-chronic liver failure - The Newer Paradigm. Sandeep Satsangi, Yogesh. K Chawla. Indian College of Physicians Monograph 2017.
  • NASH: Do we really have an Effective Treatment? Sandeep Satsangi, Ajay Duseja. (Association of physicians of India 'Medicine update' 2017).
  • Dhiman RK, Satsangi S. Autoimmune diseases of the liver. Indian J Med Res. 2017 Jan; 145(1): 151–153.

    Field of Expertise

  • Complex Hepatobiliary Conditions
  • Non-alcoholic fatty liver disease
  • Alcoholic liver diseases
  • Cirrhosis of the liver
  • Acute liver failure
  • Liver Cancer
  • Liver Transplantation
  • Liver Cancer
  • Liver Transplantation
  • Languages Spoken

  • English
  • Hindi
  • Telugu
  • Kannada
  • Awards & Achievements

  • MD: Best outgoing student 2011 batch, scored first rank in the Cardiology-Respiratory Medicine exam, and secured first prize in the M.D intercollegiate quiz competition (2013) held at Cochin, India.
  • DM: Topped the exam held at the distinguished institute of PGI, Chandigarh in 2016.
  • He also received the FIRST prize in the plenary session for the best paper award for an oral presentation on “Monocyte HLA-DR expression, neutrophil oxidative burst capacity and cytokine analysis in patients with decompensated cirrhosis with and without acute-on-chronic liver failure (ACLF)” in Delhi.
  • Served as the Assistant Editor of the prestigious Journal of Clinical and Experimental Hepatology from July 2016 to July 2017, which is an International peer-reviewed journal of Hepatology.
  • Actively assisted Prof. R.K Dhiman and his team in the process of devising the scientific program and abstract evaluation for INASL 2016 & ISHEN 2017.
  • Was actively involved in training the community level physicians in the state of Punjab, India in the field of Hepatology under the guidance of Prof. R.K Dhiman via. the program ‘ECHO’, which involves telemedicine services.
  • Talks & Publications

  • Hepatic Visceral Crisis in Breast Cancer: Targeting an Old Enemy With “Precision” Resulting in Excellent Outcomes. JCEH 2025.
  • Exploring the prevalence, clinical parameters and impact of culture proven ascitic fluid infections in Cirrhosis: A multi-center study. JCEH 2025.
  • The potential liver donor with tuberculosis: A fresh look at international recommendations based on a survey of practice in Indian liver transplant centres. National Med Journal 2022.
  • Fatal Herpes Simplex Hepatitis in a Live Liver Donor. JCEH 2025.
  • Kaur S, Satsangi S et al. Awareness regarding hepatitis B prevention and management of hepatitis B virus positive patients among nurses. J Postgrad Med Edu Res 2023.
  • Satsangi S, Taneja S. Abnormal LFTs in Rheumatic diseases. Rheumatology Clinics 2023.
  • Satsangi S, Taneja S. Anti Tubercular Therapy related hepatitis. Tuberculosis and GIT 2022.
  • Satsangi S et al. Current and new drugs for COVID 19 treatment and its effects on the liver. J Clin Transl Hepatol 2021.
  • Decentralized Care with Generic Direct-Acting Antivirals in the Management of Chronic Hepatitis C in a Public Health Care Setting. J Hepatol. July 2019.
  • Direct-acting antiviral Therapy Is Safe and Effective in Pediatric Chronic Hepatitis C: The Public Health Perspective. J Pediatr Gastroenterol Nutr. 2019.
  • Pre-Emptive Transjugular Intrahepatic Portosystemic Shunt for Acute Variceal Bleed: Choose Your Patient Well! Hepatology 2019.
  • Noradrenaline for Hepatorenal Syndrome in Patients with Acute-on Chronic Liver Failure: Hope Remains! Hepatology 2018
  • Satsangi S. Response to terlipressin in hepatorenal syndrome- Predict to prognosticate! Clin Gastroenterol Hepatol. 2018.
  • Satsangi S. Post-Paracentesis Hemoperitoneum - Time to Become More Careful! Liver Int. 2018.
  • Satsangi S. To use entecavir, tenofovir disoproxil fumarate or tenofovir alafenamide. It's all about choosing the right patient! Eur J Gastroenterol Hepatol. 2018.
  • Satsangi S. Immune-tolerant chronic hepatitis B infection- Is the liver really tolerating? J Clin Exp Hepatol. 2018.
  • Satsangi S. Khat consumption induced chronic liver disease: is it all autoimmune?. J Liver Res Disord Ther. 2018;4(2):64.
  • Satsangi S, Mehta M, Duseja A, Taneja S, Dhiman RK, Chawla Y. Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C. J Gastroenterol Hepatol. 2016.
  • Mehta M, Satsangi S, Duseja A, et al. Can Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Co-Exist? J Clin Exp Hepatol 2017.
  • Sakpal M, Satsangi S, Mehta M et al. Vitamin D supplementation in patients with Nonalcoholic Fatty Liver Disease - A Randomised Controlled Trial. J Gastroenterol Hepatol Open 2017.
  • Satsangi S, Acharya V, Kini H, Anupama K. An unusual cause of lung mass in a young female. Lung India. 2014;31(2):188-90.
  • Satsangi S, Chawla YK. Viral hepatitis: Indian scenario. Med J Armed Forces India. 2016;72(3):204-10.
  • Dhiman RK, Satsangi S, Grover GS, Puri P. Tackling the burden of hepatitis C in Punjab, India. J Clin Exp Hepatol. 2016 Sep;6(3):224-232.
  • Chronic hepatitis C: Suspect, Detect & Treat. Sandeep Satsangi, Yogesh. K Chawla. (Association of physicians of India 'Medicine update' 2015).
  • Recent advances in the medical management of portal hypertesion. Sandeep Satsangi, Yogesh. K Chawla. (Association of physicians of India 'Medicine update' 2016)
  • How will I manage CHC genotype-1 after the introduction of Direct-Acting Antivirals. Sandeep Satsangi, Yogesh. K Chawla. (Progress in Gastroenterology & Hepatology 2015)
  • Satsangi S, Gupta N. Rheumatologic Manifestations of Viral Hepatitis B and C. Hepatitis. 2015.
  • Satsangi S, Dhiman RK. Combating the wrath of viral hepatitis in India. Indian J Med Res. 2016 Jul; 144(1): 1–5.
  • Treatment of Hepatitis B in the Indian subcontinent. Sandeep Satsangi, Yogesh. K Chawla. Indian College of Physicians Monograph 2017.
  • Acute-on-chronic liver failure - The Newer Paradigm. Sandeep Satsangi, Yogesh. K Chawla. Indian College of Physicians Monograph 2017.
  • NASH: Do we really have an Effective Treatment? Sandeep Satsangi, Ajay Duseja. (Association of physicians of India 'Medicine update' 2017).
  • Dhiman RK, Satsangi S. Autoimmune diseases of the liver. Indian J Med Res. 2017 Jan; 145(1): 151–153.
  • Overview

  • Dr. Sandeep Satsangi is a highly skilled hepatologist and liver transplant physician in Old Airport Road, Bangalore. He is currently practising as a Lead Consultant - Hepatology at Manipal Hospital, Old Airport Road, Bangalore, bringing over a decade of specialised clinical experience in the diagnosis, management, and advanced treatment of complex liver diseases. Renowned for his precision, evidence-based approach, and patient-centric care, Dr. Satsangi has earned a reputation as one of the best hepatologists in Bangalore, offering world-class services in liver disease management, liver transplantation, and multiorgan care.

  • Dr. Satsangi’s medical journey began with an MBBS from MNR Medical College, Sangareddy where he secured distinctions in several subjects like pharmacology, microbiology, social & preventive medicine, and paediatrics. He subsequently did an M.D in Internal Medicine from Kasturba Medical College, Mangalore, under Manipal University. Dr Satsangi was also awarded as the university topper in his MD examination. Dr Satsangi then specialised in the field of liver diseases and liver transplantation by completing a prestigious D.M in Hepatology from the highly reputed PGIMER, Chandigarh. Dr. Satsangi consistently topped his class and the exit exam held by the institution. He also performed extensive research and published extensively in the field of hepatology and received several accolades for his academic excellence. His early exposure to complex liver pathologies during his senior residency at PGIMER equipped him with extensive hands-on experience in managing acute and chronic liver disorders, hepatitis, cirrhosis, portal hypertension, and liver failure.

  • Currently, at Manipal Hospitals, Bangalore, Dr. Satsangi leads a comprehensive liver care programme encompassing advanced hepatology consultations, liver transplantation, and management of multiorgan complications associated with liver disease. His expertise spans from managing fatty liver, alcohol related liver disease, liver cancer, acute-on-chronic liver failure (ACLF), viral hepatitis, autoimmune liver diseases, cirrhosis, and liver complications arising from systemic illnesses. He is also actively involved in pre- and post-liver transplant care, where he plays a pivotal role in optimizing patients prior to a liver transplant and ensures long term follow-up of recipients for optimal outcomes. Dr. Satsangi also plays a key role in evaluation of live liver donors & their perioperative management ensuring their smooth recovery and liver regeneration.

  • Dr. Satsangi has contributed significantly to medical research and education. He has presented multiple award-winning oral and poster papers at national and international conferences, including ISGCON, APASL, AASLD, and INASL. His publications cover a broad spectrum of hepatology topics, such as liver transplantation outcomes, management of hepatitis C with direct-acting antivirals, liver disease in systemic disorders, and innovative strategies for ACLF management including extracorporeal therapies for liver failure. These contributions have positioned him as a leader and academic mentor in the field of hepatology.

  • In addition to his clinical and academic accomplishments, Dr. Satsangi has actively worked to improve community awareness and physician training in liver care. He has collaborated on telemedicine initiatives, such as the ‘ECHO’ program in Punjab, training community-level physicians in early detection and management of liver diseases. He also served as Assistant Editor of the Journal of Clinical and Experimental Hepatology which is the official journal of INASL, gaining experience in peer-reviewed publication processes and scientific review.

  • Fluent in English, Hindi, Telugu, Punjabi, and Kannada, Dr. Satsangi is known for his approachable and empathetic communication with patients and families, guiding them through complex treatment decisions with clarity and compassion. Combining advanced clinical skills, international-standard protocols, and personalised patient care, he is recognised as the best hepatologist in Bangalore for patients seeking specialised liver disease management and transplant care. His practice seamlessly integrates cutting-edge medical science with an unwavering commitment to improving patient outcomes, making him a preferred choice for patients across Bangalore and surrounding regions.

    Awards & Achievements

  • MD: Best outgoing student 2011 batch, scored first rank in the Cardiology-Respiratory Medicine exam, and secured first prize in the M.D intercollegiate quiz competition (2013) held at Cochin, India.
  • DM: Topped the exam held at the distinguished institute of PGI, Chandigarh in 2016.
  • He also received the FIRST prize in the plenary session for the best paper award for an oral presentation on “Monocyte HLA-DR expression, neutrophil oxidative burst capacity and cytokine analysis in patients with decompensated cirrhosis with and without acute-on-chronic liver failure (ACLF)” in Delhi.
  • Served as the Assistant Editor of the prestigious Journal of Clinical and Experimental Hepatology from July 2016 to July 2017, which is an International peer-reviewed journal of Hepatology.
  • Actively assisted Prof. R.K Dhiman and his team in the process of devising the scientific program and abstract evaluation for INASL 2016 & ISHEN 2017.
  • Was actively involved in training the community level physicians in the state of Punjab, India in the field of Hepatology under the guidance of Prof. R.K Dhiman via. the program ‘ECHO’, which involves telemedicine services.
  • Field of Expertise

  • Complex Hepatobiliary Conditions
  • Non-alcoholic fatty liver disease
  • Alcoholic liver diseases
  • Cirrhosis of the liver
  • Acute liver failure
  • Liver Cancer
  • Liver Transplantation
  • Liver Cancer
  • Liver Transplantation
  • Languages Spoken

  • English
  • Hindi
  • Telugu
  • Kannada
  • Talks & Publications

  • Hepatic Visceral Crisis in Breast Cancer: Targeting an Old Enemy With “Precision” Resulting in Excellent Outcomes. JCEH 2025.
  • Exploring the prevalence, clinical parameters and impact of culture proven ascitic fluid infections in Cirrhosis: A multi-center study. JCEH 2025.
  • The potential liver donor with tuberculosis: A fresh look at international recommendations based on a survey of practice in Indian liver transplant centres. National Med Journal 2022.
  • Fatal Herpes Simplex Hepatitis in a Live Liver Donor. JCEH 2025.
  • Kaur S, Satsangi S et al. Awareness regarding hepatitis B prevention and management of hepatitis B virus positive patients among nurses. J Postgrad Med Edu Res 2023.
  • Satsangi S, Taneja S. Abnormal LFTs in Rheumatic diseases. Rheumatology Clinics 2023.
  • Satsangi S, Taneja S. Anti Tubercular Therapy related hepatitis. Tuberculosis and GIT 2022.
  • Satsangi S et al. Current and new drugs for COVID 19 treatment and its effects on the liver. J Clin Transl Hepatol 2021.
  • Decentralized Care with Generic Direct-Acting Antivirals in the Management of Chronic Hepatitis C in a Public Health Care Setting. J Hepatol. July 2019.
  • Direct-acting antiviral Therapy Is Safe and Effective in Pediatric Chronic Hepatitis C: The Public Health Perspective. J Pediatr Gastroenterol Nutr. 2019.
  • Pre-Emptive Transjugular Intrahepatic Portosystemic Shunt for Acute Variceal Bleed: Choose Your Patient Well! Hepatology 2019.
  • Noradrenaline for Hepatorenal Syndrome in Patients with Acute-on Chronic Liver Failure: Hope Remains! Hepatology 2018
  • Satsangi S. Response to terlipressin in hepatorenal syndrome- Predict to prognosticate! Clin Gastroenterol Hepatol. 2018.
  • Satsangi S. Post-Paracentesis Hemoperitoneum - Time to Become More Careful! Liver Int. 2018.
  • Satsangi S. To use entecavir, tenofovir disoproxil fumarate or tenofovir alafenamide. It's all about choosing the right patient! Eur J Gastroenterol Hepatol. 2018.
  • Satsangi S. Immune-tolerant chronic hepatitis B infection- Is the liver really tolerating? J Clin Exp Hepatol. 2018.
  • Satsangi S. Khat consumption induced chronic liver disease: is it all autoimmune?. J Liver Res Disord Ther. 2018;4(2):64.
  • Satsangi S, Mehta M, Duseja A, Taneja S, Dhiman RK, Chawla Y. Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C. J Gastroenterol Hepatol. 2016.
  • Mehta M, Satsangi S, Duseja A, et al. Can Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Co-Exist? J Clin Exp Hepatol 2017.
  • Sakpal M, Satsangi S, Mehta M et al. Vitamin D supplementation in patients with Nonalcoholic Fatty Liver Disease - A Randomised Controlled Trial. J Gastroenterol Hepatol Open 2017.
  • Satsangi S, Acharya V, Kini H, Anupama K. An unusual cause of lung mass in a young female. Lung India. 2014;31(2):188-90.
  • Satsangi S, Chawla YK. Viral hepatitis: Indian scenario. Med J Armed Forces India. 2016;72(3):204-10.
  • Dhiman RK, Satsangi S, Grover GS, Puri P. Tackling the burden of hepatitis C in Punjab, India. J Clin Exp Hepatol. 2016 Sep;6(3):224-232.
  • Chronic hepatitis C: Suspect, Detect & Treat. Sandeep Satsangi, Yogesh. K Chawla. (Association of physicians of India 'Medicine update' 2015).
  • Recent advances in the medical management of portal hypertesion. Sandeep Satsangi, Yogesh. K Chawla. (Association of physicians of India 'Medicine update' 2016)
  • How will I manage CHC genotype-1 after the introduction of Direct-Acting Antivirals. Sandeep Satsangi, Yogesh. K Chawla. (Progress in Gastroenterology & Hepatology 2015)
  • Satsangi S, Gupta N. Rheumatologic Manifestations of Viral Hepatitis B and C. Hepatitis. 2015.
  • Satsangi S, Dhiman RK. Combating the wrath of viral hepatitis in India. Indian J Med Res. 2016 Jul; 144(1): 1–5.
  • Treatment of Hepatitis B in the Indian subcontinent. Sandeep Satsangi, Yogesh. K Chawla. Indian College of Physicians Monograph 2017.
  • Acute-on-chronic liver failure - The Newer Paradigm. Sandeep Satsangi, Yogesh. K Chawla. Indian College of Physicians Monograph 2017.
  • NASH: Do we really have an Effective Treatment? Sandeep Satsangi, Ajay Duseja. (Association of physicians of India 'Medicine update' 2017).
  • Dhiman RK, Satsangi S. Autoimmune diseases of the liver. Indian J Med Res. 2017 Jan; 145(1): 151–153.
  • Overview

  • Dr. Sandeep Satsangi is a highly skilled hepatologist and liver transplant physician in Old Airport Road, Bangalore. He is currently practising as a Lead Consultant - Hepatology at Manipal Hospital, Old Airport Road, Bangalore, bringing over a decade of specialised clinical experience in the diagnosis, management, and advanced treatment of complex liver diseases. Renowned for his precision, evidence-based approach, and patient-centric care, Dr. Satsangi has earned a reputation as one of the best hepatologists in Bangalore, offering world-class services in liver disease management, liver transplantation, and multiorgan care.

  • Dr. Satsangi’s medical journey began with an MBBS from MNR Medical College, Sangareddy where he secured distinctions in several subjects like pharmacology, microbiology, social & preventive medicine, and paediatrics. He subsequently did an M.D in Internal Medicine from Kasturba Medical College, Mangalore, under Manipal University. Dr Satsangi was also awarded as the university topper in his MD examination. Dr Satsangi then specialised in the field of liver diseases and liver transplantation by completing a prestigious D.M in Hepatology from the highly reputed PGIMER, Chandigarh. Dr. Satsangi consistently topped his class and the exit exam held by the institution. He also performed extensive research and published extensively in the field of hepatology and received several accolades for his academic excellence. His early exposure to complex liver pathologies during his senior residency at PGIMER equipped him with extensive hands-on experience in managing acute and chronic liver disorders, hepatitis, cirrhosis, portal hypertension, and liver failure.

  • Currently, at Manipal Hospitals, Bangalore, Dr. Satsangi leads a comprehensive liver care programme encompassing advanced hepatology consultations, liver transplantation, and management of multiorgan complications associated with liver disease. His expertise spans from managing fatty liver, alcohol related liver disease, liver cancer, acute-on-chronic liver failure (ACLF), viral hepatitis, autoimmune liver diseases, cirrhosis, and liver complications arising from systemic illnesses. He is also actively involved in pre- and post-liver transplant care, where he plays a pivotal role in optimizing patients prior to a liver transplant and ensures long term follow-up of recipients for optimal outcomes. Dr. Satsangi also plays a key role in evaluation of live liver donors & their perioperative management ensuring their smooth recovery and liver regeneration.

  • Dr. Satsangi has contributed significantly to medical research and education. He has presented multiple award-winning oral and poster papers at national and international conferences, including ISGCON, APASL, AASLD, and INASL. His publications cover a broad spectrum of hepatology topics, such as liver transplantation outcomes, management of hepatitis C with direct-acting antivirals, liver disease in systemic disorders, and innovative strategies for ACLF management including extracorporeal therapies for liver failure. These contributions have positioned him as a leader and academic mentor in the field of hepatology.

  • In addition to his clinical and academic accomplishments, Dr. Satsangi has actively worked to improve community awareness and physician training in liver care. He has collaborated on telemedicine initiatives, such as the ‘ECHO’ program in Punjab, training community-level physicians in early detection and management of liver diseases. He also served as Assistant Editor of the Journal of Clinical and Experimental Hepatology which is the official journal of INASL, gaining experience in peer-reviewed publication processes and scientific review.

  • Fluent in English, Hindi, Telugu, Punjabi, and Kannada, Dr. Satsangi is known for his approachable and empathetic communication with patients and families, guiding them through complex treatment decisions with clarity and compassion. Combining advanced clinical skills, international-standard protocols, and personalised patient care, he is recognised as the best hepatologist in Bangalore for patients seeking specialised liver disease management and transplant care. His practice seamlessly integrates cutting-edge medical science with an unwavering commitment to improving patient outcomes, making him a preferred choice for patients across Bangalore and surrounding regions.

    Talks & Publications

  • Hepatic Visceral Crisis in Breast Cancer: Targeting an Old Enemy With “Precision” Resulting in Excellent Outcomes. JCEH 2025.
  • Exploring the prevalence, clinical parameters and impact of culture proven ascitic fluid infections in Cirrhosis: A multi-center study. JCEH 2025.
  • The potential liver donor with tuberculosis: A fresh look at international recommendations based on a survey of practice in Indian liver transplant centres. National Med Journal 2022.
  • Fatal Herpes Simplex Hepatitis in a Live Liver Donor. JCEH 2025.
  • Kaur S, Satsangi S et al. Awareness regarding hepatitis B prevention and management of hepatitis B virus positive patients among nurses. J Postgrad Med Edu Res 2023.
  • Satsangi S, Taneja S. Abnormal LFTs in Rheumatic diseases. Rheumatology Clinics 2023.
  • Satsangi S, Taneja S. Anti Tubercular Therapy related hepatitis. Tuberculosis and GIT 2022.
  • Satsangi S et al. Current and new drugs for COVID 19 treatment and its effects on the liver. J Clin Transl Hepatol 2021.
  • Decentralized Care with Generic Direct-Acting Antivirals in the Management of Chronic Hepatitis C in a Public Health Care Setting. J Hepatol. July 2019.
  • Direct-acting antiviral Therapy Is Safe and Effective in Pediatric Chronic Hepatitis C: The Public Health Perspective. J Pediatr Gastroenterol Nutr. 2019.
  • Pre-Emptive Transjugular Intrahepatic Portosystemic Shunt for Acute Variceal Bleed: Choose Your Patient Well! Hepatology 2019.
  • Noradrenaline for Hepatorenal Syndrome in Patients with Acute-on Chronic Liver Failure: Hope Remains! Hepatology 2018
  • Satsangi S. Response to terlipressin in hepatorenal syndrome- Predict to prognosticate! Clin Gastroenterol Hepatol. 2018.
  • Satsangi S. Post-Paracentesis Hemoperitoneum - Time to Become More Careful! Liver Int. 2018.
  • Satsangi S. To use entecavir, tenofovir disoproxil fumarate or tenofovir alafenamide. It's all about choosing the right patient! Eur J Gastroenterol Hepatol. 2018.
  • Satsangi S. Immune-tolerant chronic hepatitis B infection- Is the liver really tolerating? J Clin Exp Hepatol. 2018.
  • Satsangi S. Khat consumption induced chronic liver disease: is it all autoimmune?. J Liver Res Disord Ther. 2018;4(2):64.
  • Satsangi S, Mehta M, Duseja A, Taneja S, Dhiman RK, Chawla Y. Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C. J Gastroenterol Hepatol. 2016.
  • Mehta M, Satsangi S, Duseja A, et al. Can Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Co-Exist? J Clin Exp Hepatol 2017.
  • Sakpal M, Satsangi S, Mehta M et al. Vitamin D supplementation in patients with Nonalcoholic Fatty Liver Disease - A Randomised Controlled Trial. J Gastroenterol Hepatol Open 2017.
  • Satsangi S, Acharya V, Kini H, Anupama K. An unusual cause of lung mass in a young female. Lung India. 2014;31(2):188-90.
  • Satsangi S, Chawla YK. Viral hepatitis: Indian scenario. Med J Armed Forces India. 2016;72(3):204-10.
  • Dhiman RK, Satsangi S, Grover GS, Puri P. Tackling the burden of hepatitis C in Punjab, India. J Clin Exp Hepatol. 2016 Sep;6(3):224-232.
  • Chronic hepatitis C: Suspect, Detect & Treat. Sandeep Satsangi, Yogesh. K Chawla. (Association of physicians of India 'Medicine update' 2015).
  • Recent advances in the medical management of portal hypertesion. Sandeep Satsangi, Yogesh. K Chawla. (Association of physicians of India 'Medicine update' 2016)
  • How will I manage CHC genotype-1 after the introduction of Direct-Acting Antivirals. Sandeep Satsangi, Yogesh. K Chawla. (Progress in Gastroenterology & Hepatology 2015)
  • Satsangi S, Gupta N. Rheumatologic Manifestations of Viral Hepatitis B and C. Hepatitis. 2015.
  • Satsangi S, Dhiman RK. Combating the wrath of viral hepatitis in India. Indian J Med Res. 2016 Jul; 144(1): 1–5.
  • Treatment of Hepatitis B in the Indian subcontinent. Sandeep Satsangi, Yogesh. K Chawla. Indian College of Physicians Monograph 2017.
  • Acute-on-chronic liver failure - The Newer Paradigm. Sandeep Satsangi, Yogesh. K Chawla. Indian College of Physicians Monograph 2017.
  • NASH: Do we really have an Effective Treatment? Sandeep Satsangi, Ajay Duseja. (Association of physicians of India 'Medicine update' 2017).
  • Dhiman RK, Satsangi S. Autoimmune diseases of the liver. Indian J Med Res. 2017 Jan; 145(1): 151–153.
  • Overview

  • Dr. Sandeep Satsangi is a highly skilled hepatologist and liver transplant physician in Old Airport Road, Bangalore. He is currently practising as a Lead Consultant - Hepatology at Manipal Hospital, Old Airport Road, Bangalore, bringing over a decade of specialised clinical experience in the diagnosis, management, and advanced treatment of complex liver diseases. Renowned for his precision, evidence-based approach, and patient-centric care, Dr. Satsangi has earned a reputation as one of the best hepatologists in Bangalore, offering world-class services in liver disease management, liver transplantation, and multiorgan care.

  • Dr. Satsangi’s medical journey began with an MBBS from MNR Medical College, Sangareddy where he secured distinctions in several subjects like pharmacology, microbiology, social & preventive medicine, and paediatrics. He subsequently did an M.D in Internal Medicine from Kasturba Medical College, Mangalore, under Manipal University. Dr Satsangi was also awarded as the university topper in his MD examination. Dr Satsangi then specialised in the field of liver diseases and liver transplantation by completing a prestigious D.M in Hepatology from the highly reputed PGIMER, Chandigarh. Dr. Satsangi consistently topped his class and the exit exam held by the institution. He also performed extensive research and published extensively in the field of hepatology and received several accolades for his academic excellence. His early exposure to complex liver pathologies during his senior residency at PGIMER equipped him with extensive hands-on experience in managing acute and chronic liver disorders, hepatitis, cirrhosis, portal hypertension, and liver failure.

  • Currently, at Manipal Hospitals, Bangalore, Dr. Satsangi leads a comprehensive liver care programme encompassing advanced hepatology consultations, liver transplantation, and management of multiorgan complications associated with liver disease. His expertise spans from managing fatty liver, alcohol related liver disease, liver cancer, acute-on-chronic liver failure (ACLF), viral hepatitis, autoimmune liver diseases, cirrhosis, and liver complications arising from systemic illnesses. He is also actively involved in pre- and post-liver transplant care, where he plays a pivotal role in optimizing patients prior to a liver transplant and ensures long term follow-up of recipients for optimal outcomes. Dr. Satsangi also plays a key role in evaluation of live liver donors & their perioperative management ensuring their smooth recovery and liver regeneration.

  • Dr. Satsangi has contributed significantly to medical research and education. He has presented multiple award-winning oral and poster papers at national and international conferences, including ISGCON, APASL, AASLD, and INASL. His publications cover a broad spectrum of hepatology topics, such as liver transplantation outcomes, management of hepatitis C with direct-acting antivirals, liver disease in systemic disorders, and innovative strategies for ACLF management including extracorporeal therapies for liver failure. These contributions have positioned him as a leader and academic mentor in the field of hepatology.

  • In addition to his clinical and academic accomplishments, Dr. Satsangi has actively worked to improve community awareness and physician training in liver care. He has collaborated on telemedicine initiatives, such as the ‘ECHO’ program in Punjab, training community-level physicians in early detection and management of liver diseases. He also served as Assistant Editor of the Journal of Clinical and Experimental Hepatology which is the official journal of INASL, gaining experience in peer-reviewed publication processes and scientific review.

  • Fluent in English, Hindi, Telugu, Punjabi, and Kannada, Dr. Satsangi is known for his approachable and empathetic communication with patients and families, guiding them through complex treatment decisions with clarity and compassion. Combining advanced clinical skills, international-standard protocols, and personalised patient care, he is recognised as the best hepatologist in Bangalore for patients seeking specialised liver disease management and transplant care. His practice seamlessly integrates cutting-edge medical science with an unwavering commitment to improving patient outcomes, making him a preferred choice for patients across Bangalore and surrounding regions.

  • Field of Expertise

  • Complex Hepatobiliary Conditions
  • Non-alcoholic fatty liver disease
  • Alcoholic liver diseases
  • Cirrhosis of the liver
  • Acute liver failure
  • Liver Cancer
  • Liver Transplantation
  • Liver Cancer
  • Liver Transplantation
  • Languages Spoken

  • English
  • Hindi
  • Telugu
  • Kannada
  • Awards & Achievements

  • MD: Best outgoing student 2011 batch, scored first rank in the Cardiology-Respiratory Medicine exam, and secured first prize in the M.D intercollegiate quiz competition (2013) held at Cochin, India.
  • DM: Topped the exam held at the distinguished institute of PGI, Chandigarh in 2016.
  • He also received the FIRST prize in the plenary session for the best paper award for an oral presentation on “Monocyte HLA-DR expression, neutrophil oxidative burst capacity and cytokine analysis in patients with decompensated cirrhosis with and without acute-on-chronic liver failure (ACLF)” in Delhi.
  • Served as the Assistant Editor of the prestigious Journal of Clinical and Experimental Hepatology from July 2016 to July 2017, which is an International peer-reviewed journal of Hepatology.
  • Actively assisted Prof. R.K Dhiman and his team in the process of devising the scientific program and abstract evaluation for INASL 2016 & ISHEN 2017.
  • Was actively involved in training the community level physicians in the state of Punjab, India in the field of Hepatology under the guidance of Prof. R.K Dhiman via. the program ‘ECHO’, which involves telemedicine services.

FAQ's

Patients visit Dr. Sandeep Satsangi, a leading Lead Consultant - Hepatology at Manipal Hospitals Old Airport Road - Bengaluru, for expert care and advanced treatments. Known for accurate diagnoses and patient centric care, Dr. Sandeep Satsangi is a trusted choice for exceptional medical support.